Navigation Links
Frost & Sullivan Accolade for Swissray's Exceptional Dedication to its Customers
Date:2/25/2013

LONDON, Feb. 25, 2013 /PRNewswire/ --Based on its recent analysis of the digital radiography (DR) market, Frost & Sullivan recognizes Swissray Medical AG (Swissray) with the 2012 Europe Customer Value Enhancement Award.

Swissray has pioneered the development of proprietary, state-of-the-art direct digital radiography (ddR) technology. Its exceptional solutions – ddRVersa, ddRCruze, ddRFormula  and ddRElement - represent a perfect blend of best-in-class quality and performance with affordability.

Customization and flexibility are the hallmarks of Swissray's products, which can be modified to meet the actual needs of healthcare facilities, helping end-users achieve maximum efficiency.

Two important reasons end users seeking to replace their installed base with a DR system are workflow optimization and throughput improvement. Radiation dose optimization is also becoming a crucial competitive aspect in the market. High costs of DR systems and quality of maintenance services are among the other focus points for end-users.

"Swissray's strong market position is based on its high-quality, high-performance solutions that can be customized to meet client needs," noted Frost & Sullivan Healthcare Industry Analyst Dominika Grzywinska . "The company's innovative and user-friendly solutions are considered an industry benchmark. Moreover, flexible product pricing enables the company to address the needs of all types of end-users, ranging from large teaching hospitals to smaller facilities with lower throughput."

All Swissray products are available with the company's proprietary software, eXpert. This not only significantly improves workflow, but also minimizes the risk of mistakes. Here again, the software can be adjusted to specific end-user requirements.

"Swissray's products are designed with a special focus on dose minimization,"
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
2. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
3. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
4. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
5. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
6. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
7. Gains from a Growing Patient Pool for Cardiac Rhythm Management Devices Offset by Lower Product Pricing, Observes Frost & Sullivan
8. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
9. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
10. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
11. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 ... medications, yet only half of consumers surveyed are aware ... have ever used use them, according to findings from ... a community service partnership focused on improving the health ... The online survey polled 1,000 men and women, ages ...
(Date:8/3/2015)... --  The Intellectual Property and Science business of ... intelligent information for businesses and professionals announced the ... Factbook , the biopharmaceutical industry,s leading resource of ... R&D, the analysis identifies a surge in global ... sales to reach $1.3 trillion by 2018. It ...
(Date:8/3/2015)... , Aug. 3, 2015 Discovery Laboratories, ... company focused on developing aerosolized KL4 surfactant therapies ... and webcast at 8:30 a.m. Eastern Time on Tuesday ... discuss the 2015 second quarter financial results along ... issue a press release announcing the second quarter ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2
... 11 InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical ... it has completed enrollment of a 360 patient Phase ... of PPAR gamma (SPPARM) for the treatment of Type ... high dose active comparator (45mg Actos(R)) and placebo controlled ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... 29th Annual Health Care Conference on Tuesday, March 17, ... Place in Boston, MA. A live webcast of the ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on the ... team, can now be accessed at http://www.AISHealth.com . The data is free to ... Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Rock Your ... Pop & Rock Beauty Bash Tour. In addition, they have signed Lexi Noel, dubbed ... will appear in forthcoming print and overall branding opportunities for the company. , ...
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, 2015 , ... ... is all but universal, though the desire for invasive surgery to achieve this ideal ... can offer the results people crave without the high cost or lengthy recovery time, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... awarded independent educational grants in support of an interaction simulation session entitled "NOACS: ... activity is jointly provided by Medical Learning Institute Inc. and EDUmotion US LLC. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful rollout of its ... Cath Lab Accreditation in an Academic Setting, and The Importance of PVI Accreditation. , ... taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3
... SPRINGS, Fla., Jan. 31 Tigris Pharmaceuticals,Inc., a privately ... of Mr. Pedro Granadillo to its Board of Directors., ... Eli Lilly and,Company ("Lilly") until 2004 when he retired ... Policy Committee, which was comprised of its top,seven executives. ...
... ... Rebranding, COLUMBIA, S.C., Jan. ... involves the sole sponsorship for the,"One-on- One" match-up analysis to run ... remainder of the regular NCAA season., (Logo: http://www.newscom.com/cgi-bin/prnh/20080109/CLW033LOGO ...
... Guidance -, BRAINTREE, Mass., Jan. 31 Haemonetics,Corporation ... 2008 GAAP net,revenues of $135 million, up 18.6%; net ... share of $0.54, down 12.1%., Third quarter fiscal ... and 2008 and certain tax benefits in 2007, was ...
... took the B vitamin for one year before conception, study ... to help prevent birth defects, folic acid may also help ... study that included almost 40,000 women, a team of U.S. ... supplements for a year or longer before conception had a ...
... Strong International Performance and InLight ... Equipment Sales, GLENWOOD, ... and environmental radiation,monitoring, today reported record performance in its first fiscal quarter,ended ... Revenue reached a record $21.8 million on higher international revenues ...
... /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX:,DAX) (Nasdaq: DRAX ... Quarter and Year End 2007 on Thursday February 7, ... audio webcast at 10:00 a.m.,(ET) to discuss the results ... the conference call and webcast are as follows:, ...
Cached Medicine News:Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Colonial Life Goes 'One On One' With ESPN 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 3Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 4Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 5Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 6Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 7Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 8Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 9Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 10Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 11Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 12Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 13Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 14Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 15Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 16Health News:Folic Acid May Help Prevent Premature Birth 2Health News:Folic Acid May Help Prevent Premature Birth 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 2Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 4Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 5Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 6Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 7Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 2Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 3Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 4
... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: